AIIMS
Analyst IMS Investment Management Services’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $748K | Hold |
1,425
| – | – | 0.03% | 99 |
|
|
2025
Q1 | $904K | Hold |
1,425
| – | – | 0.04% | 92 |
|
|
2024
Q4 | $1.02M | Hold |
1,425
| – | – | 0.04% | 82 |
|
|
2024
Q3 | $1.5M | Hold |
1,425
| – | – | 0.06% | 67 |
|
|
2024
Q2 | $1.5M | Hold |
1,425
| – | – | 0.06% | 59 |
|
|
2024
Q1 | $1.37M | Hold |
1,425
| – | – | 0.06% | 56 |
|
|
2023
Q4 | $1.25M | Hold |
1,425
| – | – | 0.07% | 54 |
|
|
2023
Q3 | $1.19M | Hold |
1,425
| – | – | 0.07% | 48 |
|
|
2023
Q2 | $1.01M | Hold |
1,425
| – | – | 0.07% | 53 |
|
|
2023
Q1 | $1.16M | Sell |
1,425
-62
| -4% | -$50.3K | 0.09% | 48 |
|
|
2022
Q4 | $1.07M | Sell |
1,487
-290
| -16% | -$209K | 0.09% | 53 |
|
|
2022
Q3 | $1.23M | Sell |
1,777
-73
| -4% | -$50.5K | 0.12% | 47 |
|
|
2022
Q2 | $1.09M | Sell |
1,850
-370
| -17% | -$219K | 0.1% | 58 |
|
|
2022
Q1 | $1.55M | Sell |
2,220
-630
| -22% | -$440K | 0.14% | 49 |
|
|
2021
Q4 | $1.83M | Buy |
2,850
+40
| +1% | +$25.7K | 0.17% | 53 |
|
|
2021
Q3 | $1.7M | Sell |
2,810
-75
| -3% | -$45.4K | 0.21% | 51 |
|
|
2021
Q2 | $1.61M | Buy |
2,885
+80
| +3% | +$44.7K | 0.19% | 53 |
|
|
2021
Q1 | $1.33M | Buy |
2,805
+740
| +36% | +$350K | 0.18% | 54 |
|
|
2020
Q4 | $998K | Buy |
+2,065
| New | +$998K | 0.17% | 59 |
|
|
2018
Q4 | – | Sell |
-140
| Closed | -$57 | – | 151 |
|
|
2018
Q3 | $57 | Buy |
+140
| New | +$57 | 0.01% | 129 |
|